Patent · US Active

Widespread gene delivery to the retina using systemic administration of AAV vectors

US9114161B2 · kind B2 · utility

4Cited by

0References

25Claims

0Family size

Assignees

ASSOCIATION INSTITUT DE MYOLOGIE · FR
GENETHON · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
Universite Pierre Et Marie Curie (Paris 6) · FR

Inventor

Martine Barkats · Charenton-le-Pont, FR

Key dates

Filing date	Jul 30, 2010
Grant date	Aug 25, 2015
Priority date	—
Expiry date	Jul 30, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14143
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods, in particular to methods based on systemic administration of scAAV, for delivering genes to cells of the retina of mammals, and in particular to photoreceptor cells, ganglion cells, glial cells, inner nuclear layer cells or cells of the retinal pigmented epithelium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.